WebNews

Please enter a web search for web results.

NewsWeb

Wyoming Tribune Eagle
wyomingnews. com > online_features > press_releases > hanchorbio-tests-broader-ambitions-for-hcb101-through-inxmed-partnership > article_33d3fd67-d8cc-51b0-83e2-392fd85d0824. html

Hanchor Bio Tests Broader Ambitions for HCB101 Through Inx Med Partnership

9+ hour, 15+ min ago  (417+ words) FBD Biologics, a subsidiary of Hanchor Bio, has signed a strategic memorandum of understanding (MOU) with Inx Med. Taiwan-listed biotech looks to expand the value of its lead oncology asset through combination research with late-stage cancer drug resistance specialist Inx…...

Symbols: nasdaq:inbx
Los Angeles Times
latimes. com > opinion > story > 2026-07-09 > medicare-medicaid-fraud-detection-prevention

Contributor: Medicare's new approach to halting fraud is paying off

21+ min ago  (951+ words) Last year, we wrote in the Los Angeles Times that the Centers for Medicare and Medicaid Services was done chasing criminals after we'd already handed them money. We said we were building something different " a prevention-first operation that would detect…...

Symbols: btc-usd,eth-usd
Google News
startuphub. ai > people > john-muir

John Muir - Chief Medical Information Officer

1+ hour, 59+ min ago  (68+ words) Startup Hub. ai John Muir is the Chief Medical Information Officer at Providence, a leading healthcare organization. He is responsible for overseeing the organization's medical information systems and driving digital transformation in healthcare delivery. John Muir is currently Chief Medical…...

Symbols: btc-usd
open PR. com
openpr. com > news > 4571538 > how-dev-technosys-ceo-tarun-nagar-is-transforming-healthcare

How Dev Technosys CEO Tarun Nagar Is Transforming Healthcare Software Development in 2026

2+ hour, 49+ min ago  (61+ words) open PR. com How Dev Technosys CEO Tarun Nagar Is Transforming Healthcare Software Development in 2026 Press release from: Dev Technosys Permanent link to this press release: You can edit or delete your press release How Dev Technosys CEO Tarun Nagar…...

Symbols: d05.S0,u11.S0,z74.S0,1j7.S0,v3m.si,i07.S0
Whalesbook
whalesbook. com > corporate-news > English > healthcarebiotech > One Source-Specialty-Pharma-No-Material-Impact-from-DRL-Supply-Delay-Expands-Capacity > 6a4f2daeadc106bd16f8e292

One Source Specialty Pharma: No Material Impact from DRL Supply Delay; Expands Capacity

1+ hour, 15+ min ago  (409+ words) One Source Specialty Pharma reassured investors that a supply delay from partner Dr. Reddy's Laboratories has no material impact. The company highlighted diversified demand and confirmed new manufacturing capacity coming online this quarter. One Source Specialty Pharma has stated that…...

Symbols: btc-usd
Streamline
streamlinefeed. co. ke > news > astrazeneca-loses-kes-3-3-trillion-in-value-after-major-heart-drug-trial-fails

Astra Zeneca Loses KES 3. 3 Trillion in Value After Major Heart Drug Trial Fails

52+ min ago  (272+ words) A Phase III trial failure for the ATTR-CM drug Wainua has wiped "20 billion from Astra Zeneca's market capitalization, sending shockwaves through global markets. The failure stems from the CARDIO-TTRansform study, the largest clinical trial ever conducted for ATTR-CM, encompassing 1, 432 patients…...

Symbols: lse:azn,nasdaq:azn
Techsauce
techsauce. co > en > exec-insight > in-conversation-with-eric-tse

In Conversation with Eric Tse, Heir to One of China's Leading Pharmaceutical Groups, on Lessons from SBP Group's 20-Year Path to Global Success

59+ min ago  (722+ words) July 9, 2026 | By Techsauce Team Eric Tse defines the company's identity as pioneer innovation, or being an innovation pioneer rather than a follower. But that was only the beginning. The next goal Eric is pushing the organization toward is to move…...

Symbols: btc-usd
Trading View
tradingview. com > news > reuters. com, 2026: newsml_L8 N43 B0 K0: 0-novo-nordisk-india-exec-says-awiqli-of-2100-units-is-priced-at-7833-rupees

Novo Nordisk India Exec Says AWIQLI Of 2100 Units Is Priced At 7833 Rupees

1+ hour, 50+ min ago  (33+ words) Trading View Novo Nordisk India Exec Says AWIQLI Of 2100 Units Is Priced At 7833 Rupees More news from Reuters...

Symbols: nyse:nvo
Sharecast
sharecast. com > news > news-and-announcements > astrazeneca-shares-slide-on-failure-of-cardiomyopathy-trial--22966834. html

Astra Zeneca shares slide on failure of cardiomyopathy trial

1+ hour, 31+ min ago  (155+ words) Astra Zeneca said on Thursday that the phase 3 CARDIO-TTRansform trial of Wainua in adults with transthyretin-mediated amyloid cardiomyopathy did not meet its primary endpoint, failing to show a statistically significant benefit against placebo on the composite measure of cardiovascular mortality…...

Symbols: lse:azn,nasdaq:azn
Google News
asktraders. com > analysis > astrazeneca-shares-slide-9-as-wainua-drug-fails-key-heart-trial

Astra Zeneca shares slide 9% as Wainua drug fails key heart trial | Ask Traders. com %

1+ hour, 16+ min ago  (209+ words) Astra Zeneca lost about "19 billion in market value on Thursday after its Wainua drug missed the main goal of a late-stage heart disease trial. Astra Zeneca (LSE: AZN) shares dipped sharply in early trading on Thursday after the company said…...

Symbols: lse:azn